Brief: Comera Life Sciences Announces Issuance Of U.S. Patent For Proprietary Excipients In Sqore Platform
22/06/2022 13:25
June 22 (Reuters) - Comera Life Sciences Holdings Inc
CMRA.O :
* COMERA LIFE SCIENCES ANNOUNCES ISSUANCE OF U.S. PATENT FOR
PROPRIETARY EXCIPIENTS IN SQORE PLATFORM
Source text for Eikon: ID:nBw56RLr4a
Further company coverage: CMRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Comera Life Sciences Holdings
See all newsBrief: Comera Life Sciences Holdings Says William Wexler Resigned From Company's Board Of Directors Effective Immediately
Brief: Comera Life Sciences Announces Process Exploring Strategic Alternatives
Brief: Comera Life Sciences Holdings - On Nov 15, Got Notice From Nasdaq That Nasdaq Hearings Panel Has Determined To Delist Common Stock And Warrants Of Co
Brief: Comera Life Sciences Appoints Dorothy Clarke To Board Of Directors
Brief: Comera Life Sciences Announces Completion Of $4.1 Million Private Placement